← FDA Drug Approvals (Drugs@FDA)

ERTUGLIFLOZIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HETERO LABS LTD V · Approved 2024-09-17

Drug application

FDA Application #

ANDA217071

Application type

Abbreviated New Drug Application (Generic)

Brand name

ERTUGLIFLOZIN

Generic name

Ertugliflozin

Active ingredients

ERTUGLIFLOZIN

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

HETERO LABS LTD V

First approval

2024-09-17

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown